Accordingly, insulin-stimulated mTOR activation, as determined by the difference between basal and insulin-induced S6K1 phosphorylation, was found to be significantly higher in insulin-treated lean individuals, whereas it remained unchanged in the T2DM group [37]. Here, INS is linked to type 2 diabetes mellitus.